Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
<h4>Background</h4>Sickle cell disease (SCD), a congenital hemolytic anemia that exacts terrible global morbidity and mortality, is driven by polymerization of mutated sickle hemoglobin (HbS) in red blood cells (RBCs). Fetal hemoglobin (HbF) interferes with this polymerization, but HbF is epigenetic...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science (PLoS)
2017-09-01
|
| Serier: | PLoS Medicine |
| Online adgang: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002382&type=printable |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
